# Long-tErm Effects of Enhanced eXternal CountErpuLsation

Study · id `cardio:ct-nct05913778` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05913778](<https://clinicaltrials.gov/study/NCT05913778>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05913778

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT05913778. Randomized; no masking; primary purpose treatment. Start 2020-12-10 (actual); primary completion 2021-12-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT05913778, source copy `cardio:ctgov-nct05913778-2025-04-09`, retrieved 2026-10-26)
- Started: 2020-12-10 (actual) (ClinicalTrials.gov record NCT05913778, source copy `cardio:ctgov-nct05913778-2025-04-09`, retrieved 2026-10-26)
- Primary completion: 2021-12-10 (actual) (ClinicalTrials.gov record NCT05913778, source copy `cardio:ctgov-nct05913778-2025-04-09`, retrieved 2026-10-26)
- Completion: 2025-01-15 (actual) (ClinicalTrials.gov record NCT05913778, source copy `cardio:ctgov-nct05913778-2025-04-09`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT05913778, source copy `cardio:ctgov-nct05913778-2025-04-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05913778-2025-04-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Long-tErm Effects of Enhanced eXternal CountErpuLsation
- Acronym: EXCEL
- Condition: Coronary Artery Disease
- Condition: Chronic Heart Failure
- Intervention (Device): Enhanced external counterpulsation
- Lead sponsor: I.M. Sechenov First Moscow State Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: I.M. Sechenov First Moscow State Medical University (`cardio:org-i-m-sechenov-first-moscow-state-medical-university`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: The EXCEL Study: Long-term Observation of the Effectiveness of Drug and Non-drug Rehabilitation in Patients with Ischemic Heart Failure (`cardio:pubmed-38323440`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 98023c922b1ba80ad0c4e0e1022324dca504f32d41b78fe1423e54d31f32b9b5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
